R.D. Gelber - Concepedia

Author

R.D. Gelber

International Breast Cancer Study Group

Also Known As

R D Gelber, R Gelber, R. D. Gelber, R. Gelber, R.D Gelber, R.D. Gelber, RichardD. Gelber

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

International Breast Cancer Study Group European Institute of Oncology Dana-Farber Cancer Institute University Hospital of Bern Ospedale regionale di Lugano

About

R.D. Gelber is an author at International Breast Cancer Study Group specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	15	1K
2	Health Sciences	6	6	639
3	Nursing	1	1	25
4	Public Health	1	1	25
5	Biostatistics	1	1	39

R.D. Gelber

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. R.D. Gelber, Aron Goldhirsch Journal of Clinical Oncology Surgical OncologyBreast OncologyCancer ManagementGynecologyPharmacotherapy	1986	233
Elimination of malignant clonogenic cells from human bone marrow using multiple monoclonal antibodies and complement. Robert C. Bast, Paolo de Fabritiis, Jeffrey M. Lipton, PubMed Cell TherapyMalignant Clonogenic CellsImmunologyPathologyImmunophenotyping	1985	128
A Quality-Adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Adjuvant Radiation Therapy and Chemotherapy for Resectable Rectal Cancer R.D. Gelber, Aron Goldhirsch, Bernard F. Cole, JNCI Journal of the National Cancer Institute	1996	128
BIG 1–98: Randomized double-blind phase III study to evaluate letrozole (L) vs. tamoxifen (T) as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer B. J. Thurlimann, Aparna Keshaviah, H.T. Mouridsen, Journal of Clinical Oncology Endocrine OncologyBreast OncologyHealth SciencesMedicineClinical Trials	2005	120
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials Aparna Keshaviah, Silvia Dellapasqua, Nicole Rotmensz, Annals of Oncology Breast Cancer RecurrenceBreast OncologyCancer EpidemiologyMedicineCancer Recurrence	2007	105
Effect of systemic adjuvant treatment on first sites of breast cancer relapse Aron Goldhirsch, R.D. Gelber, Karen N. Price, The Lancet Surgical OncologyBreast OncologyMedicineFirst SitesBreast Cancer	1994	77
Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies. Aron Goldhirsch, R.D. Gelber PubMed Surgical OncologyBreast OncologyCancer ManagementAdjuvant ChemotherapyPharmacotherapy	1986	64
The concept of an overview of cancer clinical trials with special emphasis on early breast cancer. R.D. Gelber, A. Goldhirsch Journal of Clinical Oncology International CooperationBreast OncologyEarly Breast CancerMedicineProspective Protocol	1986	52
VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up Sibylle Loibl, Jacek Jassem, Amir Sonnenblick, Annals of Oncology Breast OncologyMedicinePathologyBreast CancerCancer Treatment	2022	50
Randomized controlled trial of ovarian function suppression plus tamoxifen versus the same endocrine therapy plus chemotherapy: is chemotherapy necessary for premenopausal women with node-positive, endocrine-responsive breast cancer? First results of International Breast Cancer Study Group Trial 11–93 Beat Thürlimann, K.N. Price, M. Castiglione, The Breast	2001	46

Page 1